ES517540A0 - Derivados salicilicos de n-acetilcisteina. - Google Patents
Derivados salicilicos de n-acetilcisteina.Info
- Publication number
- ES517540A0 ES517540A0 ES517540A ES517540A ES517540A0 ES 517540 A0 ES517540 A0 ES 517540A0 ES 517540 A ES517540 A ES 517540A ES 517540 A ES517540 A ES 517540A ES 517540 A0 ES517540 A0 ES 517540A0
- Authority
- ES
- Spain
- Prior art keywords
- acetylcysteine
- acid
- acetilcisteina
- reaction
- salicylic derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 abstract 2
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 abstract 2
- 229960004308 acetylcysteine Drugs 0.000 abstract 2
- 229960001138 acetylsalicylic acid Drugs 0.000 abstract 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 abstract 2
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 abstract 1
- 150000008064 anhydrides Chemical class 0.000 abstract 1
- 230000001760 anti-analgesic effect Effects 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 230000001754 anti-pyretic effect Effects 0.000 abstract 1
- 239000002221 antipyretic Substances 0.000 abstract 1
- 239000012736 aqueous medium Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 abstract 1
- 230000000510 mucolytic effect Effects 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 abstract 1
- 229960004889 salicylic acid Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 150000007970 thio esters Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
- C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
- C07C323/59—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton with acylated amino groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Pulmonology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT25198/81A IT1194117B (it) | 1981-11-20 | 1981-11-20 | Derivati salicilici di n-acetilcisteina |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES8402258A1 ES8402258A1 (es) | 1984-01-16 |
| ES517540A0 true ES517540A0 (es) | 1984-01-16 |
Family
ID=11215991
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES517540A Granted ES517540A0 (es) | 1981-11-20 | 1982-11-19 | Derivados salicilicos de n-acetilcisteina. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US4567163A (en]) |
| EP (1) | EP0080229B1 (en]) |
| JP (1) | JPS58146560A (en]) |
| KR (1) | KR890000618B1 (en]) |
| AT (1) | ATE12102T1 (en]) |
| CA (1) | CA1202618A (en]) |
| DE (1) | DE3262569D1 (en]) |
| ES (1) | ES517540A0 (en]) |
| IT (1) | IT1194117B (en]) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU574360B2 (en) * | 1983-05-13 | 1988-07-07 | Reichert, D. | Antisnoring agent |
| IT1206515B (it) * | 1983-08-09 | 1989-04-27 | Guidotti & C Spa Labor | N-acetilcisteina ederivati 2',4's-carbossimetilcisteina ad-difluoro-4-idrossi-(1,1'-bifenil)attivita' antinfiammatoria, 3-carbossilici della mucolitica, procedimento per laloro preparazione e relative composizioni farmaceutiche. |
| IT1194474B (it) * | 1983-11-23 | 1988-09-22 | Magis Farmaceutici | Derivati della cisteina,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono |
| US5637616A (en) * | 1993-06-18 | 1997-06-10 | Arcturus Pharmaceutical Corporation | Method for treating diseases mediated by proteases |
| AU7176094A (en) * | 1993-06-18 | 1995-01-17 | Arcturus Pharmaceutical Corporation | Method for treating hyperkeratosis and diseases mediated by proteases |
| AU2825295A (en) * | 1994-06-13 | 1996-01-05 | Arcturus Pharmaceutical Corporation | Method for the treatment, prevention or minimization of hair loss |
| GB2320431B (en) * | 1996-12-20 | 2000-08-30 | Johnson & Johnson Medical | Compositions for the treatment of chronic wounds |
| CN102088965B (zh) * | 2008-05-13 | 2013-05-08 | 根梅迪卡治疗公司 | 水杨酸盐(酯)缀合物在制备用于治疗代谢性病症的药物中的应用 |
| WO2010106083A1 (en) * | 2009-03-16 | 2010-09-23 | Genmedica Therapeutics Sl | Combination therapies for treating metabolic disorders |
| EP2408443A1 (en) | 2009-03-16 | 2012-01-25 | Genmedica Therapeutics SL | Anti-inflammatory and antioxidant conjugates useful for treating metabolic disorders |
| US8466197B2 (en) | 2010-12-14 | 2013-06-18 | Genmedica Therapeutics Sl | Thiocarbonates as anti-inflammatory and antioxidant compounds useful for treating metabolic disorders |
| WO2013037984A1 (en) | 2011-09-16 | 2013-03-21 | Genmedica Therapeutics Sl | Anti-inflammatory and antioxidant conjugates useful for treating metabolic disorders |
| WO2013037985A1 (en) | 2011-09-16 | 2013-03-21 | Genmedica Theraputics Sl | Pharmaceutical combinations including anti-inflammatory and antioxidant conjugates useful for treating metabolic disorders |
| EP3674297A1 (en) | 2013-11-08 | 2020-07-01 | Promentis Pharmaceuticals, Inc. | Substituted n-acetyl-l-cysteine derivatives and related compounds |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR4619M (en]) * | 1965-02-01 | 1966-11-28 | ||
| US4268456A (en) * | 1979-09-24 | 1981-05-19 | Ppg Industries, Inc. | Process for preparing chlorothiolformates |
-
1981
- 1981-11-20 IT IT25198/81A patent/IT1194117B/it active
-
1982
- 1982-11-12 DE DE8282201443T patent/DE3262569D1/de not_active Expired
- 1982-11-12 EP EP82201443A patent/EP0080229B1/en not_active Expired
- 1982-11-12 AT AT82201443T patent/ATE12102T1/de not_active IP Right Cessation
- 1982-11-16 CA CA000415702A patent/CA1202618A/en not_active Expired
- 1982-11-16 US US06/442,044 patent/US4567163A/en not_active Expired - Lifetime
- 1982-11-19 KR KR8205229A patent/KR890000618B1/ko not_active Expired
- 1982-11-19 ES ES517540A patent/ES517540A0/es active Granted
- 1982-11-20 JP JP57204423A patent/JPS58146560A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| IT1194117B (it) | 1988-09-14 |
| JPS58146560A (ja) | 1983-09-01 |
| IT8125198A0 (it) | 1981-11-20 |
| ES8402258A1 (es) | 1984-01-16 |
| DE3262569D1 (en) | 1985-04-18 |
| ATE12102T1 (de) | 1985-03-15 |
| KR890000618B1 (ko) | 1989-03-22 |
| KR840002350A (ko) | 1984-06-25 |
| EP0080229B1 (en) | 1985-03-13 |
| EP0080229A1 (en) | 1983-06-01 |
| CA1202618A (en) | 1986-04-01 |
| JPH059424B2 (en]) | 1993-02-04 |
| US4567163A (en) | 1986-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES517540A0 (es) | Derivados salicilicos de n-acetilcisteina. | |
| FI942049A0 (fi) | Bentsofuranyyli- ja tiofenyylialkaanikarboksyylihappojohdannaisia | |
| SE8005890L (sv) | Salter av (+)-katekin, deras framstellning och anvendning, och kompositioner innehallande dessa salter | |
| ES8707514A1 (es) | Procedimiento para preparar nuevos tetrahidro-benzotiazoles. | |
| ES2126355T3 (es) | Procedimiento para la preparacion de creatina o monohidrato de creatina. | |
| ES8800254A1 (es) | Procedimiento para la obtencion de nuevos derivados de la pristinamicina iib. | |
| PT86314A (de) | Zytostatisch wirksame anthracyclinderivate | |
| SE8005714L (sv) | Acetoximetyl-penamforeningar anvendbara som beta-laktamasinnibitorer | |
| SE7609495L (sv) | N-tetrahydrofurfuryl-noroximorfon, dess syraadditionssalter, lekemedel innehallande dessa samt forfarande for framstellning derav | |
| DK164176A (da) | Carboxylsyreamider, fremgangsmade til deres fremstilling samt deres anvendelse som legemidler | |
| DE3785104D1 (de) | Pharmazeutisch nuetzliche thiazolidin-4-karbonsaeure-derivate. | |
| GB1448547A (en) | Derivative of phenylacetic acid | |
| ATE35811T1 (de) | Derivat der acetylsalicylsaeure, seine herstellung und dieses enthaltende pharmazeutische kompositionen. | |
| JPS5340779A (en) | Optically active tolpertisone, their preparation and pharmaceuticals containting the same | |
| ES534958A0 (es) | Procedimiento de preparar derivados cisteinicos | |
| DK599885A (da) | Trienamidforbindelser og farmaceutisk acceptable salte heraf med antiinflammatorisk og analgetisk virkning samt farmaceutisk komposition indeholdende disse | |
| JPS52128293A (en) | Preparation of 7-aminocephalosporanic acid and its derivatives | |
| KR900701838A (ko) | 어류 crf | |
| SE8402361L (sv) | Nya acylaminofenolderivat | |
| ES8801636A1 (es) | Un procedimiento para preparar nuevos derivados de imidazol | |
| ES8800144A1 (es) | Procedimiento de obtencion de un tioester de la n-acetilcisteina y de sus sales de interes terapeutico | |
| FR2044356A5 (en) | 2-phenyl propionyl salicylic acid and salts - analgesics and antipyretics | |
| DK550177A (da) | Basisk alkylerede dithiosalicylsyreamider fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler | |
| FR2470111B1 (fr) | Derives de la decaprenylamine, leurs sels acides d'addition et composition pharmaceutique utilisant ces produits | |
| SU565494A1 (ru) | ω-орто-хлоранилид α-изобутил-β-метилглутаровой кислоты или его натриевая соль, проявляющие противовоспалительную и анальгезирующую активность |